ALIFE
Strong Sell
Adamjee Life Assurance Share Price Today, Live PSX Chart & Forecast (PSX: ALIFE) Adamjee Life Assurance Company Limited
Open
Rs 31.17
High
Rs 32.13
Low
Rs 31.17
Prev close
Rs 31.37
Volume
26
Turnover
Rs 0.0M
AI verdict · rule-engine-v2
Strong Sell
53% confidence · Short Term
Our model is bearish on ALIFE. It has called this stock correctly 44.4% of the time over 153 out-of-sample checks. See what drove this ↓
Target
Rs 29.47
Exp. return
-6.1%
ALIFE share price and analysis
Adamjee Life Assurance Company Limited (ALIFE) last traded at Rs 31.37 on the Pakistan Stock Exchange, where it closed unchanged on the session of 7 September 2026. Only 26 shares, a turnover of Rs 816 changed hands — a nominal amount, at which a single order moves the quoted price and the close is not a reliable mark. Over the past year the share has traded between Rs 31.17 and Rs 43.64, putting the current price close to its 12-month low.
The price sits below both its 20-day (32.70) and 50-day (32.65) moving averages, which is the configuration usually read as a downtrend. The 14-day RSI is 42.6, a neutral reading. ADX at 11.7 indicates a weak or rangebound trend.
The company is capitalised at roughly Rs 8.2 billion and is classified under Other. It trades on a price-to-earnings ratio of 7.6, meaning the market is paying about Rs 7.6 for every rupee of annual earnings. Earnings per share stand at Rs 5.01. The trailing dividend yield is 0.27%, which is the income a holder receives at the current price before any capital movement. Return on equity is 19.1%. A beta of 1.18 means the share has historically moved more sharply than the wider market.
ALIFE ranks 17th of 54 Other companies by market value. Its price-to-earnings ratio of 7.6 compares with the Other median of 10.1, so it is priced at a clear discount to its sector. Its trailing dividend yield of 0.27% sits below the 3.42% median for the sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.
Our forecasting model currently reads ALIFE as strong sell over a short term horizon, at 53% confidence. Its target price is Rs 29.47, an expected return of -6.1%. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.
This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.
ALIFE technical indicators — RSI, MACD & moving averages
Price chart
RSI (14)
MACD (12, 26, 9)
RSI 14
42.6
Stoch %K
7.1
ADX 14
11.7
Williams %R
-92.9
SMA 20
32.70
SMA 50
32.65
MACD
-0.260
ATR 14
0.634
BB Upper
34.74
BB Lower
30.66
Momentum
-0.23
Tech score
35
ALIFE AI forecast & accuracy
rule-engine-v2directional accuracy over 153 backtested 10-day forecasts on this stock's history
- Target
- Rs 29.47
- Stop
- Rs 32.32
- Support
- Rs 31.17
- Resistance
- Rs 35.27
- Exp. return
- -6.06%
- Risk
- 60.83/100
Why
ALIFE shows strongly bearish conditions. Overall score 45/100. Drivers: Price below the 50-day average (downtrend); Histogram negative — momentum fading; Oversold (%K 7); Fundamental score 68/100. Suggested action: Strong Sell; trend and momentum favour caution. This is an automated model assessment, not financial advice.
Generated by rule-engine-v2 from the indicators above. It does not read news, filings or management changes — see how this works.
ALIFE fundamentals & valuation ratios
- Market cap
- Rs 8.2B
- P/E
- 7.6
- EPS
- 5.01
- P/B
- 1.2
- Div yield
- 0.27%
- ROE
- 19.1%
- Beta
- 1.18
- Volatility
- 56.6%
ALIFE price history — last 30 sessions
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Mon, 7 Sep 2026 | 31.17 | 32.13 | 31.17 | 31.37 | +0.00% | 26 |
| Fri, 4 Sep 2026 | 32.00 | 32.00 | 31.37 | 31.37 | -1.97% | 13,567 |
| Thu, 3 Sep 2026 | 32.40 | 32.40 | 32.00 | 32.00 | -1.23% | 41,439 |
| Wed, 2 Sep 2026 | 32.78 | 32.78 | 32.40 | 32.40 | -1.16% | 44,869 |
| Tue, 1 Sep 2026 | 32.67 | 32.78 | 32.67 | 32.78 | +0.34% | 6,235 |
| Mon, 31 Aug 2026 | 33.11 | 33.11 | 32.67 | 32.67 | -1.33% | 49,168 |
| Fri, 28 Aug 2026 | 31.98 | 33.11 | 31.98 | 33.11 | +3.53% | 9,991 |
| Thu, 27 Aug 2026 | 32.58 | 32.58 | 31.98 | 31.98 | -1.84% | 10,202 |
| Tue, 25 Aug 2026 | 32.40 | 32.58 | 32.40 | 32.58 | +0.56% | 73,429 |
| Mon, 24 Aug 2026 | 31.60 | 32.40 | 31.60 | 32.40 | +2.53% | 17,948 |
| Fri, 21 Aug 2026 | 31.72 | 31.72 | 31.60 | 31.60 | -0.38% | 49,632 |
| Thu, 20 Aug 2026 | 33.99 | 33.99 | 31.72 | 31.72 | -6.68% | 77,971 |
| Wed, 19 Aug 2026 | 32.67 | 33.99 | 32.67 | 33.99 | +4.04% | 61,365 |
| Tue, 18 Aug 2026 | 31.79 | 32.67 | 31.79 | 32.67 | +2.77% | 2,038 |
| Mon, 17 Aug 2026 | 32.50 | 32.50 | 31.79 | 31.79 | -2.18% | 11,428 |
| Thu, 13 Aug 2026 | 33.92 | 33.92 | 32.50 | 32.50 | -4.19% | 11,771 |
| Wed, 12 Aug 2026 | 33.92 | 33.92 | 33.92 | 33.92 | +0.00% | 66 |
| Tue, 11 Aug 2026 | 33.97 | 33.97 | 33.92 | 33.92 | -0.15% | 23,448 |
| Mon, 10 Aug 2026 | 35.27 | 35.27 | 33.97 | 33.97 | -3.69% | 9,502 |
| Fri, 7 Aug 2026 | 32.50 | 35.27 | 32.50 | 35.27 | +8.52% | 33,639 |
| Thu, 6 Aug 2026 | 32.32 | 32.50 | 32.32 | 32.50 | +0.56% | 572 |
| Wed, 5 Aug 2026 | 32.32 | 32.32 | 32.32 | 32.32 | +0.00% | 502 |
| Tue, 4 Aug 2026 | 32.32 | 32.32 | 32.32 | 32.32 | +0.00% | 29 |
| Mon, 3 Aug 2026 | 32.22 | 32.32 | 32.22 | 32.32 | +0.31% | 3,930 |
| Fri, 31 Jul 2026 | 32.22 | 32.22 | 32.22 | 32.22 | +0.00% | 10,008 |
| Thu, 30 Jul 2026 | 32.53 | 32.53 | 32.22 | 32.22 | -0.95% | 2,505 |
| Wed, 29 Jul 2026 | 32.50 | 32.53 | 32.50 | 32.53 | +0.09% | 3,675 |
| Tue, 28 Jul 2026 | 32.40 | 32.50 | 32.40 | 32.50 | +0.31% | 8,498 |
| Mon, 27 Jul 2026 | 32.26 | 32.40 | 32.26 | 32.40 | +0.43% | 2,542 |
| Fri, 24 Jul 2026 | 32.26 | 32.26 | 32.26 | 32.26 | +0.00% | 4 |
All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.
Other Other stocks
ALIFE is a Other listing. Compare it against the rest of the sector, or read what actually drives Other companies on the PSX.
All Other shares on the PSX →Learn how to read this page
-
How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
-
Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
-
How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.
ALIFE — frequently asked questions
What is ALIFE's share price today?
+
Adamjee Life Assurance Company Limited (ALIFE) last traded at Rs 31.37 on the Pakistan Stock Exchange, unchanged on the session of 7 September 2026. The day's range was Rs 31.17 to Rs 32.13 on 26 shares. These are end-of-day figures published by the exchange, not a live trading feed.
What is the 52-week high and low for ALIFE on the PSX?
+
ALIFE has traded between Rs 31.17 and Rs 43.64 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.
What is ALIFE's current dividend yield?
+
ALIFE has a trailing dividend yield of 0.27%, meaning that for every Rs 100 invested at the current price a holder received about Rs 0.27 in dividends over the last twelve months. Yield moves with the share price as well as with the payout, so a rising yield is not automatically a better income stream.
Is ALIFE Shariah-compliant on the PSX?
+
No. ALIFE is not currently in the exchange's Shariah-screened KMI All Share or KMI-30 index, so on the exchange's own screening it does not qualify as Shariah-compliant. That screening covers both the business activity and financial ratios such as interest-bearing debt, and it is reviewed periodically rather than continuously.
Which PSX indices is ALIFE part of?
+
ALIFE is a constituent of the KSE All Share. It is not in the KSE-100, the headline PSX benchmark. Index membership is taken from the exchange's own published listing for each session.
Is ALIFE expensive? What are its valuation ratios?
+
ALIFE trades on a price-to-earnings ratio of 7.6, so the market is paying about Rs 7.6 for each rupee of annual earnings, earnings per share of Rs 5.01, a price-to-book ratio of 1.16 and a return on equity of 19.1%. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.
What is the AI forecast for ALIFE?
+
Our model currently reads ALIFE as strong sell over a short term horizon, at 53% confidence, with a target price of Rs 29.47. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its backtested hit rate on this specific stock is published on the page, and it is not investment advice.
Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.
About this data
Prices, volumes and indicators for ALIFE are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.
PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.